Lehr Donald P. sold $127K of PGEN
Lehr Donald P. (Chief Legal Officer) sold 29,131 shares of PRECIGEN, INC. (PGEN) at $4.36 ($0.13M total) on 2026-05-28.
How this was made
The 30-second read
Why it matters
The disclosure provides a concrete datapoint on insider behavior (open-market sale by CLO) but lacks any new operational or clinical development that would re-rate the company’s fundamentals.
Market read
Traders may monitor for follow-on insider activity or correlate with upcoming corporate catalysts, but the filing alone is unlikely to drive a major repricing.
What to watch
No context is given on total insider holdings changes, prior sales cadence, or whether other officers/board members also sold/bought around the same period.
Background
The article is an SEC Form 4 disclosure of an insider’s transaction in Precigen common stock.
Ticker impact
Pre-arranged 10b5-1 plan was not used; Chief Legal Officer Donald Lehr sold 29,131 shares of Precigen at $4.36 on 2026-05-28.
Low likelihood of a sustained price move; any reaction is likely limited to sentiment/flow effects around the filing date.
The filing is an SEC Form 4 insider transaction with disclosed sale size and price, but no accompanying corporate event (earnings, trial result, deal, or guidance change) is provided.
Market effects
Limited read-through to biotech/clinical pipeline peers; this is company-specific insider activity without sector-wide catalyst.
None indicated; US-listed microcap/small-cap flow only.
None indicated.
Counterpoint
The sale may be routine liquidity/compensation-related and does not necessarily signal negative fundamentals, especially without evidence of other concurrent insider selling.
Key entities
- issuerPRECIGEN, INC.
Subject of the insider transaction disclosure (Form 4).
- insiderDonald P. Lehr
Chief Legal Officer who sold shares; transaction reported as open-market sale without a pre-arranged 10b5-1 plan.
